Proactive's Robin Davison publishes fresh research note on Poolbeg PharmaMarch 09, 2023 at 07:53 AM EST
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001. Contact DetailsProactive UK Ltd +44 20 7989 0813 
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|